GlassScriptPhysician profile
Donald B Middleton
NPI 1609815299
$257,940.31
in general payments reported to CMS, 2019-2025
11 companies · $93K in 2025
The $93K reported for 2025 was more than what 99% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30K · 2020: $11K · 2021: $30K · 2022: $21K · 2023: $35K · 2024: $38K · 2025: $93K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $86K · Consulting Fee: $57K · Travel and Lodging: $20K · Food and Beverage: $2,846.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $86,307.50 |
| Consulting Fee | $57,092.66 |
| Travel and Lodging | $19,732.30 |
| Food and Beverage | $2,845.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $68,737.97 | 2023-2025 | Capvaxive, Enflonsia |
| Pfizer INC. | $62,927.70 | 2019-2025 | |
| Seqirus USA INC | $42,438.32 | 2019-2025 | Flucelvax Quadrivalent, Fluad, Flucelvax |
| Sanofi Pasteur INC. | $34,271.14 | 2019-2024 | |
| Modernatx, INC. | $20,150.00 | 2021-2025 | Moderna Covid-19 Vaccine |
| Dynavax Technologies Corporation | $12,455.00 | 2021-2024 | Heplisav-B |
| Novavax INC | $5,888.77 | 2023 | Novavax Covid-19 Vaccine, Adjuvanted |
| Pfizer International LLC | $4,671.41 | 2019 | |
| Bavarian Nordic A/S | $3,000.00 | 2020 | |
| Valneva USA, INC. | $2,400.00 | 2022 | |
| Glaxosmithkline, LLC. | $1,000.00 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donald Middleton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.